We provide our proprietary diagnostic approach, including our unique contrast agent, Combidex, to save the lives of hundreds of cancer patients annually. We educate as many healthcare professionals as possible worldwide to enable them to improve their diagnostic methods and reach a much more accurate and reliable diagnostics of their patients.
Staten Biotechnology
Staten Biotechnology aims to develop novel and innovative strategies for the prevention of cardiovascular events, the largest unmet medical need in dyslipidemia.